Bleeding due to thrombocytopenia

💠 Acute leukemia causes bone marrow failure, leading to decreased platelet production (thrombocytopenia).

💠 Low platelet levels impair normal clotting, resulting in easy bruising, petechiae, and recurrent nosebleeds (epistaxis).

💠 Children with leukemia commonly present with mucosal bleeding due to inadequate platelet function.

💠 The presence of blast cells crowds out normal megakaryocytes, reducing platelet formation.

💠 Bleeding tendencies are often one of the earliest clinical manifestations of leukemia.

Infections due to neutropenia

💠 Leukemic blast proliferation suppresses normal white blood cell production, especially neutrophils.

💠 Neutropenia significantly increases the risk for recurrent or severe infections.

💠 Even though total WBC count may appear elevated, the circulating cells are often immature and nonfunctional.

💠 Children may experience frequent fevers, oral ulcers, or persistent infections.

💠 Infection is a major cause of morbidity in pediatric acute leukemia.

Fatigue due to RBC deficiency

💠 Bone marrow infiltration reduces production of red blood cells, causing anemia.

💠 Anemia leads to fatigue, pallor, weakness, and shortness of breath.

💠 Reduced hemoglobin decreases oxygen delivery to tissues, resulting in cellular hypoxia.

💠 Children may show decreased activity tolerance and irritability.

💠 Anemia is a common presenting feature alongside bleeding and infection.

Hypogammaglobulinemia due to progressive infiltration of the bone marrow and lymphoid tissues

💠 Leukemic infiltration disrupts normal B-cell function, impairing antibody production.

💠 This can result in hypogammaglobulinemia, further increasing susceptibility to infections.

💠 Immune dysfunction is common due to replacement of normal lymphoid tissue by malignant cells.

💠 Decreased immunoglobulin levels weaken the body's ability to fight pathogens.

💠 Immunosuppression is both disease-related and treatment-related in leukemia.

Palpation of solid tumors on the kidneys

💠 Solid renal tumors are more characteristic of Wilms tumor, not acute leukemia.

💠 Leukemia primarily affects the bone marrow and blood, not as localized kidney masses.

💠 Cancer cells often have dysregulated cell cycle control, allowing them to progress rapidly through checkpoints.

💠 Mutations in regulatory genes such as oncogenes and tumor suppressor genes (e.g., p53) shorten the time between cell divisions.

💠 Faster cycling leads to accelerated proliferation, contributing to rapid tumor growth.

💠 Normal cells carefully regulate progression through the G1, S, G2, and M phases, whereas cancer cells bypass these controls.

💠 Shortened cell cycle time increases the total number of malignant cells in a short period.

Cancer cells do not die when they are programmed to die

💠 Normal cells undergo apoptosis (programmed cell death) when damaged or no longer needed.

💠 Cancer cells evade apoptosis due to mutations that disable cell death pathways.

💠 This resistance allows abnormal cells to survive longer than normal cells.

💠 Accumulation of cells occurs because they continue dividing without undergoing normal turnover.

💠 Failure of apoptosis is a key hallmark of malignancy and contributes significantly to tumor expansion.

Cancer cells will reach a balance between cell birth and cell death rate.

💠 Tumor growth occurs because there is loss of balance, with cell proliferation exceeding cell death.

💠 A balance would prevent progressive tumor enlargement.

Cancer cells never reach a flattened growth rate.

💠 Some tumors may slow in growth due to nutrient limitation or treatment effects.

💠 This statement is overly absolute and not physiologically accurate.

Cancer cells tend to grow rapidly

💠 While many cancers grow rapidly, this statement describes an observation rather than aphysiological mechanism.

💠 The underlying principles involve shortened cell cycles and resistance to apoptosis.

💠 Cellular atrophy is a decrease in cell size due to reduced functional demand or loss of trophic stimulation.

💠 During menopause, declining estrogen levels lead to reduced stimulation of estrogen-dependent tissues such as the uterus and vaginal epithelium.

💠 This hormonal withdrawal causes shrinkage of reproductive organs, which is a classic example of physiologic atrophy.

💠 Atrophy involves decreased protein synthesis and increased protein breakdown within the affected cells.

💠 The process is adaptive and not necessarily pathologic, as it reflects normal aging changes.

A female client with the change in uterine size as a result of pregnancy

💠 Uterine enlargement during pregnancy is due to hyperplasia and hypertrophy, not atrophy.

💠 Cells increase in size and number to support fetal development.

A hypertensive, noncompliant client who has developed a progressive increase in left ventricular mass

💠 Increased left ventricular mass is an example of hypertrophy, caused by increased workload.

💠 Cardiac muscle cells enlarge to compensate for elevated blood pressure.

A post nephrectomy client whose remaining kidney enlarges to compensate for the loss

💠 Enlargement of the remaining kidney is compensatory hypertrophy.

💠 The existing cells increase in size to maintain adequate renal function.

💠 Cellular atrophy refers to a decrease in cell size resulting from reduced stimulation or workload.

💠 During menopause, there is a significant decline in estrogen production, which removes trophic hormonal support from reproductive tissues.

💠 The uterus and vaginal tissues undergo physiologic shrinkage due to decreased protein synthesis and cellular activity.

💠 This process represents a normal adaptive response to aging rather than a disease state.

💠 Atrophy occurs because cells reduce their structural components when stimulation is no longer present.

A female client with the change in uterine size as a result of pregnancy

💠 Uterine enlargement during pregnancy is due to hypertrophy and hyperplasia, not atrophy.

💠 Cells increase in both size and number to accommodate fetal growth.

A hypertensive, noncompliant client who has developed a progressive increase in left ventricular mass

💠 Increased ventricular mass is an example of hypertrophy caused by chronic increased workload.

💠 Cardiac muscle fibers enlarge to compensate for elevated blood pressure.

A post nephrectomy client whose remaining kidney enlarges to compensate for the loss

💠 Enlargement of the remaining kidney is compensatory hypertrophy.

💠 The existing renal cells increase in size to maintain function.

💠 IgM antibodies are primarily responsible for ABO blood group incompatibility reactions during transfusions.

💠 Individuals naturally develop anti-A or anti-B antibodies (IgM) early in life without prior transfusion exposure.

💠 IgM is highly effective at activating the complement system, leading to rapid intravascular hemolysis of incompatible red blood cells.

💠 Because IgM is a large pentamer molecule, it remains mainly in the intravascular space, intensifying acute transfusion reactions.

💠 ABO mismatched transfusions can result in hemolysis, fever, hypotension, and acute kidney injury, all mediated by IgM-driven complement activation.

IgD

💠 IgD functions mainly as a receptor on immature B cells.

💠 It does not play a role in transfusion incompatibility reactions.

IgE

💠 IgE is primarily involved in allergic and hypersensitivity reactions.

💠 It mediates responses related to mast cells and histamine release, not ABO reactions.

IgA

💠 IgA is found mainly in mucosal secretions such as saliva and breast milk.

💠 It protects mucosal surfaces rather than mediating blood transfusion reactions.

IgG

💠 IgG is responsible for Rh incompatibility reactions, not ABO incompatibility.

💠 IgG can cross the placenta and is involved in hemolytic disease of the newborn.

💠 Histamine is released from mast cells and basophils during immune and inflammatory reactions, especially in type I hypersensitivity responses.

💠 It directly causes vasodilation of local blood vessels, which increases blood flow to the affected area and produces redness.

💠 Histamine increases capillary permeability, allowing plasma proteins and fluid to leak into surrounding tissues.

💠 The movement of fluid into interstitial spaces results in edema and swelling, which are hallmark signs of inflammation.

💠 Histamine also stimulates sensory nerve endings, contributing to itching and discomfort during allergic reactions.

Tumor necrosis factor

💠 Tumor necrosis factor (TNF) promotes systemic inflammation and fever.

💠 It contributes to immune cell activation but is not the primary mediator of immediate vasodilation and edema.

Cytokines

💠 Cytokines are signaling proteins that regulate immune responses.

💠 They coordinate inflammation but do not directly cause rapid vascular permeability changes like histamine.

Prostaglandins

💠 Prostaglandins contribute to pain and fever during inflammation.

💠 Although they influence vascular tone, histamine is the primary mediator of acute permeability and edema.

💠 Artificial active immunity occurs when a person is intentionally exposed to an antigen through vaccination to stimulate an immune response.

💠 Vaccines contain weakened, inactivated, or antigenic components of a pathogen that trigger the body to produce specific antibodies and memory cells.

💠 This immune response allows the body to mount a faster and stronger defense upon future exposure to the actual pathogen.

💠 The immunity develops over time and typically provides long-term protection due to immunologic memory.

💠 Because the antigen exposure is deliberate and the body produces its own antibodies, it is classified as artificial (man-made) and active (self-produced antibodies).

Artificial passive

💠 Artificial passive immunity involves administration of preformed antibodies, such as immunoglobulin injections.

💠 It provides immediate but temporary protection without stimulating memory cell formation.

Natural passive

💠 Natural passive immunity occurs when antibodies are transferred from mother to fetus through the placenta or breast milk.

💠 The recipient does not produce their own antibodies in this process.

Natural active

💠 Natural active immunity develops after exposure to an infectious pathogen.

💠 The immune system produces antibodies following natural infection, not vaccination.

💠 Wet gangrene occurs when tissue necrosis is accompanied by a bacterial infection, leading to rapid tissue destruction.

💠 The affected area appears moist, swollen, black or darkened, and often emits a foul odor due to bacterial decomposition.

💠 It is commonly associated with compromised blood flow combined with infection, such as in diabetic foot ulcers.

💠 Wet gangrene spreads quickly because bacteria thrive in the moist, ischemic environment.

💠 This condition is considered a medical emergency due to the high risk of sepsis.

Dry gangrene results from chronic ischemia without infection

💠 Dry gangrene develops from prolonged arterial insufficiency, leading to gradual tissue death.

💠 The affected tissue appears dark, dry, shrunken, and leathery, often described as mummified.

💠 There is typically a clear line of demarcation between viable and necrotic tissue.

💠 It progresses more slowly than wet gangrene because infection is not initially present.

💠 Dry gangrene may convert to wet gangrene if secondary infection develops.

💠 A bilirubin level of 13 mg/dL in a newborn indicates hyperbilirubinemia, which commonly manifests as jaundice.

💠 Jaundice presents as yellow discoloration of the skin and sclera, beginning on the face and progressing downward (cephalocaudal pattern).

💠 Newborns are prone to elevated bilirubin due to immature liver function, which reduces their ability to conjugate and excrete bilirubin efficiently.

💠 Increased breakdown of fetal red blood cells after birth also contributes to higher bilirubin production.

💠 Monitoring is essential because excessively high bilirubin levels can lead to kernicterus and neurological damage if untreated.

Dark-colored urine with foul odor

💠 Dark, foul-smelling urine is more suggestive of urinary tract infection, not hyperbilirubinemia.

💠 Newborn jaundice primarily affects skin and sclera rather than urine odor.

Xanthomas with swelling

💠 Xanthomas are cholesterol deposits seen in lipid disorders.

💠 They are not associated with neonatal hyperbilirubinemia.

Colicky, intermittent pain associated with formula feeding

💠 Colicky pain relates to gastrointestinal discomfort, not bilirubin elevation.

💠 Hyperbilirubinemia does not present with feeding-related abdominal pain.